BioCentury

7:00 AM GMT, Aug 13, 2015
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Distillery Therapeutics

Therapeutics: HECT domain containing E3 ubiquitin protein ligase 2 (HECTD2)

Inflammation

INDICATION: Inflammation; pulmonary

Mouse studies suggest inhibiting HECTD2 could help treat lung

Read the full 115 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.